OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

Registered Company No: 05416311

Wessex Cancer Trust Report and Financial Statements For the Year Ended 31 December 2021

(A Company Limited by Guarantee) Registered Charity No: 01110216

Wessex Cancer Trust

Report and Financial Statement

Contents

Legal and Administrative information 1
Report of the trustees 2-11
Independent auditor’s report 12-15
Consolidated statement of financial activities 16-17
Consolidated and trust balance sheets 18
Consolidated statement of cash flows 19
Notes to the financial statements 20-34

Legal and Administrative information

Charity Name Wessex Cancer Trust Company Number 05416311 Charity Registered Number 01110216

Registered Office 91-95 Winchester Road Chandlers Ford Eastleigh SO53 2GG

The Directors of the charitable company are its Trustees for the purposes of charity law.

The Trustees and Officers serving during the year and since the year end were as follows:

Board of Trustees Mrs D Cutler Chair
Mr M Miles FCA Treasurer
Dr E Arden-Close
Mr T Jones FCA joined 6 October 2021
Mr J Clough joined 6 October 2021
Ms S Bedells joined 6 October 2021
Ms R De Beer joined 6 October 2021
Mr J Plumtree joined 8 April 2022
Ms J Warwick resigned 9 March 2022
Mrs L Darby resigned 13April 2022
Mr B Rinaldi Vice Chair, resigned 30 April 2022
Mr P Towler resigned 10 May 2022
Mrs H Bodiam Secretary, resigned 28 February 2022
Mr D Daniels ACCA Secretary joined 28 February, resigned 2 May
2022
Mr D Robertson CA (SA) Secretary, joined 3 May 2022
Chief Executive Rachel Billsberry-Grass
Legal Advisors Paris Smith LLP
1 London Road
Southampton, SO15 2AE
Bankers The Royal Bank of Scotland
156 High Street
Southampton, SO14 2NP
Co-Operative Bank
PO Box 250
Delf House
Skelmersdale, WN8 6WT
Auditors Azets Audit Services
Athenia House
10-14 Andover Road
Winchester
Hampshire, SO23 7BS

1

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Chair’s Summary

Welcome to our 2021 Annual Report and Accounts. The year saw the Trust celebrate 40 years of providing cancer support for local people and despite the continued challenges posed by the second year of Covid, we saw a significant turnaround in our financial fortunes. Whilst in part this was due to the positive impact of our short-term strategy, we also benefitted from some incredibly generous legacy gifts.

Our teams continued to be agile and responsive to support thousands of people who needed our help more than ever which was a particular challenge through 2021 given the impact of Covid lockdowns and other restrictions. Wessex Cancer Trust services remain a vital part of the local cancer provision, complementing what is offered by the NHS and other charities.

Cancer often brings with it much fear and uncertainty; the potential risks of Covid meant ongoing additional anxiety and stress for many people with cancer and their loved ones. Emotional and wellbeing services have been particularly important, and our teams have delivered vital support such as counselling, complementary therapies and befriending, via phone, online and at pre-booked appointments. One example of our online support is our Sound Therapy group which offers clients calm and peaceful meditation. As one client puts it, ‘It’s like Sonja waved a magic wand to let those stresses just float away and I think there’s a good chance I’ll sleep so much better and more deeply. I feel super chilled and at peace.’

We were delighted that our Sing4Life choirs returned in person with gusto, having remained online from the first lockdown until September. Singing can help lower stress, boost immunity and lung function and improve mental health, and our informal singing groups offer a supportive community that benefit many people affected by cancer.

Our two Daisy buses operated throughout the year, with additional Covid-safe measures in place, to support cancer patients from the Isle of Wight and the Channel Islands. Part of this service is delivered under contract with the States of Jersey. We are also contracted by four of the region’s NHS hospitals to deliver counselling or complementary therapies. This partnership working enables us to cost-effectively reach more people.

The Bournemouth Centre had a busy year. In spring we were approached by property developers and asked to surrender the lease on the Centre. After careful consideration and negotiation, the Trustees took the pragmatic view to accept a surrender payment, and at the end of the year the team successfully moved to a new short-term home in the same road. The search for a new permanent home for the Centre is pending receipt of the surrender payment, which has been impacted by delays in the planning process. Consequently, the payment will be recognised in the accounts on receipt in 2022. During the year we were also able to renegotiate a number of our other leases, with new preferential deals which reduced our liabilities both in the year and in the future.

In fundraising, the continued unpredictability has meant uncertainty for event plans which was particularly frustrating given the many 40[th] anniversary celebrations we had hoped to deliver. However, we took some measured risks to respond to the great demand from supporters, and successfully delivered a number of key events with hundreds of people enjoying Rainbow Runs, Drive-In Movies and Christmas Concerts.

2

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Trust fundraising was a focus for investment in our 2020 short term strategy and in 2021 we saw this approach begin to pay dividends. Several funders including the National Lottery Fund and St James’ Place offered significant multi-year funding, which was a real vote of confidence in the charity. Overall, our income from fundraising activity reached £811,442 (2020: £711,395).

In our shops, three months of lockdown was an unpromising start to the year, but despite this we achieved strong year-end figures. During the lockdown retail staff were furloughed and we applied for available grants which helped reduce the financial impact of the closures. Once open, our retail team was highly focused on sales and gift aid, and the strong sales figures of £365,119 (2020: £292,988) give us a degree of confidence about the future of retail for the charity.

Wessex Cancer Trust has traditionally benefitted from the great generosity of supporters who choose to leave a gift in their will. This legacy income is unpredictable and can never be guaranteed and in 2020 legacy income was considerably lower than in previous years. In 2021, we saw a complete change with an unprecedented number of large legacies which provided income of £1,739,287 (2020: £72,237). The timing could not have been more welcome, and these legacies have enabled the charity to rebuild our reserves and allowed us to be more confident and ambitious in our immediate future.

The year ended with gross income of £3,123,236 (2020: £1,302,940). We also continued to drive savings across the organisation which contributed to an overall net surplus of £1,845,045 (2020: net loss £102,784). The surplus has enabled us to increase free reserves to £1,157,256 (2020: £207,720), with a further £609,437 designated against future projects.

During the year we worked on our next three-year strategy and Cancer Support for All was launched at the beginning of 2022. The Board has committed to a long-term goal of ensuring that everyone in the region has access to high quality personalised cancer support within 15 miles of home. During the next three years we will work towards that goal by developing and building our community outreach programme in partnership with others, reaching individuals in geographical areas and communities who’ve not previously accessed our services.

Our 40[th] anniversary year was remarkable in many ways and notable for many achievements. None of these would have been possible without our team of committed and passionate staff and volunteers, to whom we owe a debt of gratitude.

The charity ended the year having supported thousands of people affected by cancer across the region, and in a stronger financial position than we have been for years. As a Board, we are steadfast in our commitment to capitalise on this position of strength, continuing to grow our income and our services, for the benefit of all the people who need support now and in the future.

Thank you to all the individuals and organisations that were part of our year.

Diane Cutler, Chair of Trustees

3

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Our Approach to Safeguarding

ln 2018 the Charity Commission underlined that charities must be trusted places where people can feel safe. At Wessex Cancer Trust we have Safeguarding policies and procedures for Adults and Children which reflect current legislation such as The Mental Capacity Act 2005, Safeguarding Vulnerable Groups Act 2006 and the Care Act 2014. The Multi-Agency Safeguarding Adults Policy and Guidance (June 2020) developed by the Safeguarding Adults Boards in Hampshire, Southampton, Isle of Wight and Portsmouth, informs our training for staff and volunteers. Our CEO is our Safeguarding Lead, supported by the Head/Interim Head of Services who provides continued oversight and review of all safeguarding concerns, reporting to the Services Advisory Committee and the Board.

Our Approach to Fundraising

Wessex Cancer Trust is a member of the Fundraising Regulator and adheres to fundraising codes of practice. We employ a team of Fundraisers who work across the region. During 2021 we continued to develop a broader fundraising portfolio to mitigate the risks presented by an uncertain external environment.

On occasion we use external agencies to deliver fundraising activities. All activity is delivered to service level agreements which are monitored through regular meetings, mystery shopping and regular review of feedback and any complaints. Agencies are contractually required to ensure all fundraising activity is in accordance with all applicable legal requirements and the relevant binding codes of practice issued by the Fundraising Regulator. Professional fundraising agencies must have clear and up to date policies in place to protect vulnerable people and other members of the public from unreasonable behaviour. In 2021 no complaints about Wessex Cancer Trust fundraising practices or activities were received by the fundraising regulator.

Public Benefit

ln reviewing our aims and objectives and planning our future activities, we have referred to and complied with the duty in section 17 of the Charities Act 2011. This relates to having due regard to the Charity Commission's published general guidance on public benefit. ln particular, the Trustees consider how planned activities will contribute to the aims and objectives they have set. Our priorities are:

A cancer diagnosis is devastating. We offer emotional and practical support to help improve the wellbeing of people with cancer and their loved ones.

4

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Cancer Support Centres

The Trust has four Cancer Support Centres which are based in:

Bournemouth, Dorset Chandlers Ford, Hampshire Hythe, Hampshire Newport, Isle of Wight

Our Centres are usually open throughout the week to drop-in or referred clients. Unfortunately for much of 2021 Centres were only open to pre-booked clients. Those who attended received a warm welcome from our trained volunteer Befrienders who have a depth of understanding based on their own experiences. With the support of Befrienders, we were also able to run some outdoor support services such as our popular weekly Chandler’s Ford walking group. During 2021 our Befrienders also took a proactive role providing remote support to clients; making check-in phone calls and running remote group sessions online.

Due to the changing nature of the Covid restrictions, our well laid plans to re-open for drop-in clients were delayed until early 2022. We will continue to explore ways of using a blended provision of remote and inperson services to reach more people in different demographics, a key aim for the Board.

People who are new to Wessex Cancer Trust services are given an appointment with our Wellbeing Coordinator. Together they develop a personalised care plan based on the client’s situation and what support and services might suit their needs. During 2021 these appointments were delivered both online and in person. This was a new role from January which has helped us to give clients a more consistent experience, improve efficiency and enable us to better monitor and evaluate our services. We’re grateful to the Linbury Trust which provides funding towards this role.

Island Support

In addition to the Centre in Newport, the Trust continues to cater for the particular challenges of cancer patients from the Isle of Wight and the Channel Islands by providing the Daisy Buses in Southampton and Portsmouth. The buses offer free transport for patients, to and from the ports, hotels and hospitals.

Singing Groups

Many studies have shown the benefits of singing for both physical and mental health. Wessex Cancer Trust runs three popular Sing4 Life choirs for people living with cancer and their loved ones, engaging around 140 singers. The groups are strong communities which also provide peer support. During 2021 the choirs were primarily online, but did manage to meet in person from September to December, with Covid measures in place. Our Cosham Sing4Life group performed at our Christmas Concert in Titchfield in December.

5

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Information

Wessex Cancer Trust continues to be a source of trusted local information for people affected by cancer. Our website is updated regularly, and our Services team of staff and volunteers offer a wealth of local knowledge.

NHS Trust Partnerships - Outreach

Partnerships are an important part of our work. We worked with a number of NHS hospitals during the year, being contracted to provide counselling or complementary therapies in Southampton General, Queen Anne’s Portsmouth, Basingstoke and Bournemouth Hospitals.

Wessex Cancer Alliance and other Cancer networks

The Trust’s CEO and Head of Services represent the charity on key boards and working groups. These include the Personalised Care Programme Board run by Wessex Cancer Alliance and the Dorset Macmillan Cancer Information Services project run by the Dorset Cancer Partnership. In so doing we build partnerships, influence the local cancer agenda, and advocate for our clients.

Colleagues and Volunteers

The Trustees thank all the staff and volunteers who exemplified our values of Support, Inform, Community and Thrive. They faced the year with stoicism and determination, helping the charity to achieve tremendous results for people with cancer and their loved ones during 2021.

Volunteers are the lifeblood of Wessex Cancer Trust, and we are hugely grateful to all of the individuals who continue to support the charity in this way. The range of volunteer support we enjoy is huge and includes counselling and therapies, befriending, running support groups, helping in our shops or at a fundraising event, or providing office-based support. Volunteers are carefully vetted and trained and in 2021 we continued to offer training in listening skills, safeguarding and Covid risk management.

Financial review

Total gross income was £3,123,236 (2020: £1,302,940). In a small part, this increase reflects some of the changes we have put in place to improve our financial resilience and increase our income. However, the extraordinary leap in income would not have happened without the exceptionally generous legacies that were left to the charity during 2021. In the financial year legacy income was £1,739,287 (2020: £72,237), and of particular note was a residual share of a legacy which is worth over £1m. The Trustees are thankful to all those people who left a gift in their will of whatever size.

During 2021 we have continued to diversify our fundraising income streams to reduce risk. In our short-term strategy, we increased our focus on fundraising from trusts, major donors, individual giving and corporate fundraising. This is ongoing work which has begun to pay dividends with an increase in trust/grant income to £271,698 (2020: £214,819). It was also reassuring to see some recovery in community and event fundraising activity during the year notwithstanding the various lockdowns and restrictions. Of particular note were our hugely successful Isle of Wight fundraising events which included two Drive-In Movie weekends, the Rainbow Run and Swim for Hope.

6

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

The Trust’s income also includes retail trading, undertaken through a wholly owned subsidiary, W.C.T. Wessex Limited. The Covid pandemic caused another year of disruption and uncertainty, with lockdown closures and restrictions. In response, we accessed all the available government support grants and strived for increased profitability and Gift Aid collection when open. A new focus on online sales has shown promising results and in 2022 we will continue to develop this area. Despite the challenges of the year, our retail outlets delivered a total income of £365,119 (2020: £292,988) and a profit after taxation of £178,738 (2020: £38,719).

Our current retail outlets are in: Weeke, Winchester Chandler’s Ford Freshwater, Isle of Wight Hythe Portchester

Most of our income remains dependent on the generosity of our supporters, whether through financial donations, gifts in a will or participation in fundraising events, or by donating or buying second-hand goods in our shops. Consequently, we are so grateful to all those individuals, organisations, clubs, schools and companies that supported the charity during 2021.

A total of £513,083 was spent on raising funds (2020: £633,598) which includes the costs of running our retail shops, and expenditure on charitable activities amounted to £765,512 (2020: £772,111).

The charity remains dependent on voluntary income but as noted above was able to access various special Covid government grants during 2021. With such a marked increase in free reserves, we were able to repay the loan of £50,000 from the Bounce Back Loan Scheme, taken out in 2020. The end of year outcome was a surplus of £1,845,045 (2020: £102,784 deficit).

In our 2020 accounts we reported that the financial management of the charity had been a top priority for the new team. Throughout 2021 the charity has continued to closely monitor finances and maintain an 18– 24-month cashflow forecast. Robust evaluation of income generation activities, cost saving exercises and staying alert to opportunities to access grant or insurance money has helped to secure the financial position of the charity and protect the long-term future of the Trust.

Based on all available information the Trustees have a reasonable expectation that the Trust will be able to continue in operation and meet its liabilities as they fall due for the foreseeable future, being a period of at least one year from the date of this report. Therefore, the Trust continues to adopt the going concern basis of accounting.

Reserves Policy

Free reserves are funds that are readily realisable and exclude funds whose use is restricted or designated for a particular purpose. It also excludes funds invested in fixed assets utilised in the day to day running of the charity.

7

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

During 2021 the Trustees reviewed the appropriate level of reserves needed by the charity and agreed a level of £800,000 - £1m, representing approximately 9 months of 2021 running costs. Given the ongoing impact of the pandemic, together with the developing situation in Ukraine and the related impacts on current inflation levels, the Trustees are satisfied to retain free reserves at the upper end of this range.

At the balance sheet date of 31 December 2021, the group total reserves were £2,211,051 (2020: £366,006) of which £429,547 were restricted (2020: £130,901) and not available for general purposes. In 2021 the Trustees set aside designated funds of £609,437 (2020: £nil) from unrestricted legacy income received during the year, to enable the charity to develop, improve and expand its reach and range of services as part of the strategic plan. Group free reserves at the balance sheet date were £1,157,256 (2020: £207,720).

Plans for Future Periods

Wessex Cancer Trust will continue to offer services to support emotional health and wellbeing for cancer patients and their loved ones within the Wessex region.

During 2021 we developed a new three-year strategy Cancer Support for All which has taken account of learnings in service delivery gained during 2020. Our long-term goal is to ensure that everyone in the Wessex region can access good quality cancer support within 15 miles of home. To make that a reality, during the next three years we will be investing in a programme of community outreach to offer support to communities and geographic areas of the region that we are not currently reaching.

To fund this work, we will continue to carefully monitor and evaluate all income streams, developing further those that have the greatest potential for growth and sustainability.

Structure, Governance and Management

Background

The original Wessex Cancer Trust was established as a registered unincorporated charity (280133) under a Trust Deed dated 3 March 1980. In January 2005, the Board of Trustees decided to incorporate the charity. A new company, Wessex Cancer Trust, was incorporated under the Companies Act 1985 on 6 April 2005 and entered into the Central Register of Charities on 27 June 2005 with registered number 01110216. The assets and liabilities of the unincorporated Trust were transferred to the Company on 1 October 2005 when it commenced activities.

Governing Documents

Wessex Cancer Trust’s Articles of Association currently define the objects of the charity as:

‘For the public benefit to assist in the treatment and care of persons affected by cancer, the provision of support, education and practical advice, including raising funds to; complement and improve cancer care services by supporting patients, families and carers;

providing education and information for patients, families and professionals; promoting cancer prevention; mainly throughout Wessex including Hampshire, Dorset, Wiltshire, the Isle of Wight and the Channel Islands.’

8

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Governing Body

At 31 December 2021, the Governing Board comprised eleven Trustees, who also form the membership of the Company. Every member promises to pay a sum not exceeding £10 towards the payments of debts and liabilities of the Company if it is dissolved while he or she is a member or within 12 months after he or she ceases to be a member.

New Trustees are identified through an open recruitment process and are then elected by the Board based on having the attributes necessary to maintain the range of skills necessary for the effective direction of the Charity. Training for new Trustees includes receipt of a comprehensive induction pack and briefings from staff.

All Trustees who have served continuously for four years can choose to stand for re-election at the next Annual General Meeting. Trustees can serve a maximum of 2 four-year terms. Re-election is voted amongst all the members of the Charity to be completed at least 48 hours before the completion of the Annual General Meeting.

Decisions by the Board are made by simple majority, with the Chair taking the deciding vote in the event of a tie.

During 2021 the Trustee Board was strengthened with the arrival of four new Trustees, bringing a varied range of skills including in business and strategy, IT, Marketing and HR.

The Board meets quarterly, with the CEO and members of the Senior Leadership Team.

Delegation

The Articles of Association permit delegation of Trustees’ powers to a committee of two or more Trustees. During 2021 the Trust had six sub committees:

Governance & Risk Committee Finance & Audit Committee Human Resource Committee Service Advisory Committee Fundraising & Marketing Advisory Committee Retail Advisory Committee

The Trustees appoint a Chief Executive who is responsible for the day-to-day operations of the Charity, working alongside department heads to deliver the Trust’s work.

Management of Risks

The Trust maintains a Risk Register, which is reviewed regularly at Board and Committee meetings. Mitigation plans are in place to reduce, as far as possible, the impact or likelihood of occurrence.

9

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Remuneration

The Human Resource Committee recommends any annual cost of living increases based on the Consumer Price Index. In 2021 the staff was given a cost-of-living increase of 2% (0% in 2020) Any other salary increases are based on performance or advancement. Salaries for new roles are reviewed against market rates for similar roles in the charity sector and at the end of the year we undertook an external benchmarking exercise. This resulted in salary increases for a small number of roles, which were implemented in early 2022 along with a further cost of living rise of 3% across the board.

Trustees’ Responsibilities in relation to the Financial Statements

The Trustees (who are also directors of Wessex Cancer Trust for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the charitable group for that period. In preparing these financial statements, the trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group's transactions and disclose with reasonable accuracy at any time the financial position of the charitable group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Provision of information to auditor

Each of the persons who are Trustees at the time when this Trustees' Report is approved has confirmed that:

10

Wessex Cancer Trust (Registered Company No: 05416311)

Report of the Trustees (including director’s report)

________________

Auditor

Azets Audit Services were appointed auditors to the group and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

This report was approved by the Trustees on 17 June 2022 and signed on their behalf by:

D Cutler Chair of Trustees

Date: 17 June 2022

11

Wessex Cancer Trust (Registered Company No: 05416311

Independent auditor’s report to the trustees of Wessex Cancer Trust

________________

Independent auditor’s report to the trustees of Wessex Cancer Trust

Opinion

We have audited the financial statements of Wessex Cancer Trust (the ‘charitable parent company’) and its subsidiary (the ‘group’) for the year ended 31 December 2021 which comprise the Consolidated Statement of Financial Activities, the Consolidated Balance Sheet, the Company Balance Sheet, the Consolidated Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group & charitable parent company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

12

Wessex Cancer Trust (Registered Company No: 05416311

Independent auditor’s report to the trustees of Wessex Cancer Trust

________________

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information, except to the extent otherwise explicitly stated in our report, and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

the information given in the trustees' report, which includes the directors' report and the strategic report prepared for the purposes of company law, for the financial year for which the financial statements are prepared is consistent with the financial statements; and the strategic report and the directors' report included within the trustees' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and charitable parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic and directors’ report. We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 us to report to you if, in our opinion:

13

Wessex Cancer Trust (Registered Company No: 05416311

Independent auditor’s report to the trustees of Wessex Cancer Trust

________________

Responsibilities of trustees

As explained more fully in the statement of trustees' responsibilities, the trustees, who are also the directors of the charitable parent company for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the group & charitable parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or charitable parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Acts and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above and on the Financial Reporting Council’s website, to detect material misstatements in respect of irregularities, including fraud.

We obtain and update our understanding of the entity, its activities, its control environment, and likely future developments, including in relation to the legal and regulatory framework applicable and how the entity is complying with that framework. Based on this understanding, we identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. This includes consideration of the risk of acts by the entity that were contrary to applicable laws and regulations, including fraud.

In response to the risk of irregularities and non-compliance with laws and regulations, including fraud, we designed procedures which included:

14

Wessex Cancer Trust (Registered Company No: 05416311

Independent auditor’s report to the trustees of Wessex Cancer Trust

________________

Extent to which the audit was considered capable of detecting irregularities, including fraud (continued)

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of noncompliance. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

Use of our report

This report is made solely to the charitable parent company trustees, as a body, in accordance with part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable parent company trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the group and the charitable parent company’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

20.06.2022
Michael Tizard,Azets Audit Services ...........................................................
Chartered Accountants Athenia House
Statutory Auditor 10-14 Andover Road
Winchester
Hampshire
United Kingdom SO23 7BS

15

Wessex Cancer Trust (Registered Company No: 05416311)

Consolidated Statement of Financial Activities (including income and expenditure account) for the year ended 31 December 2021

Note
Income:
Donations
Legacies
2
Activities for raising funds
3
Other income
4
Investment income
5
Total income
Expenditure:
Costs of raising funds:
Costs of raising voluntary
income
9
Costs of activities for
raising funds
9
Expenditure on
Charitable activities:
Care
11
Education
11
Total expenditure
7
Net income/(expenditure)
before net gains/(losses)
on investments and tax
Net gains/(losses) on
investments
15
Taxation
24
Net incoming/
(outgoing) resources
before transfers
8
Transfers
21
Fund balances brought
forward at 1 January
Fund balances carried
forward at 31
December
21		 Unrestricted
Funds
Designated
Funds
Restricted
Funds
Total
Funds
Total
Funds
Year to
31-12-2021
Year to
31-12-2020
£
£
£
£
£
236,559
-
203,914
440,473
439,615
1,400,561
-
338,726
1,739,287
72,237
729,346
-
6,742
736,088
564,768
207,339
-
-
207,339
226,199
49
-
-
49
121
2,573,854
-
549,382
3,123,236
1,302,940
205,142
-
1,170
206,312
199,740
306,771
-
-
306,771
433,858
486,046
-
247,755
733,801
732,070
31,711
-
-
31,711
40,041
1,029,670
-
248,925
1,278,595
1,405,709
1,544,184
-
300,457
1,844,641
(102,769)
5
-
-
5
(15)
399
-
-
399
-
1,544,588
-
300,457
1,845,045
(102,784)
(607,626)
609,437
(1,811)
-
-
936,962
609,437
298,646
1,845,045
(102,784)
235,105
-
130,901
366,006
468,790
1,172,067
609,437
429,547
2,211,051
366,006

The statement of financial activities includes all gains and losses recognised in the year. All incoming resources and resources expended derive from continuing activities

16

Wessex Cancer Trust (Registered Company No: 05416311)

Consolidated Statement of Financial Activities (including income and expenditure account) for the year ended 31 December 2021

Note
Income:
Donations
Legacies
2
Activities for raising funds
3
Other income
4
Investment income
5
Total income
Expenditure:
Costs of raising funds:
Costs of raising voluntary
income
9
Costs of activities for
raising funds
9
Expenditure on Charitable
activities:
Care
11
Education
11
Total expenditure
7
Net income/(expenditure)
before net (losses)/gains on
investments and tax
Net (losses)/gains on
investments
15
Taxation
24
Net
incoming/(outgoing)
resources before
transfers
8
Transfers
21
Net movement in funds for the year
Fund balances brought
forward at 1 January
Fund balances carried
forward at 31 December21		 Unrestricted
Funds
£
225,450
72,237
533,348
226,199
121
1,057,355
197,147
433,858
481,860
40,041
1,152,906
(95,551)
(15)
(95,566)
1,996
(93,570)
328,675
235,105		 Restricted
Funds

£
214,165
-
31,420
-
-
245,585

2,593
-
250,210
-
252,803
(7,218)
-
-
(7,218)
(1,996)
(9,214)
140,115
130,901		 Total
FFunds
Year to
31-12-2020
£
439,615
72,237
564,768
226,199
121
1,302,940
199,740
433,858
732,070
40,041
1,405,709
(102,769)
(15)
-
(102,784)
-
(102,784)
468,790
366,006

The statement of financial activities includes all gains and losses recognised in the year. All incoming resources and resources expended derive from continuing activities.

17

Wessex Cancer Trust (Registered Company No: 05416311

Consolidated and Trust Balance Sheet as at 31 December 2021

________________

Note
Fixed assets
Tangible assets
14
Investments
15
Current assets
Debtors due within one year
16
Cash at bank and in hand
Creditors: amounts falling
due within one year
17
Net current assets
Total assets less current
liabilities
Creditors: amounts falling
due after more than one
year
18
Net assets
Funds
Restricted
20
Designated
21
Unrestricted
21
21		 Group
2021
2020
£
£
89,759
149,228
138
133
89,897
149,361
248,149
174,572
1,987,682
285,798
2,235,831
460,370
(111,057)
(186,429)
2,124,774
273,941		 Group
2021
2020
£
£
89,759
149,228
138
133
89,897
149,361
248,149
174,572
1,987,682
285,798
2,235,831
460,370
(111,057)
(186,429)
2,124,774
273,941		 Trust
(Restated
– Note 6)
2021
2020
£
£
74,948
121,843
140
135
75,088
121,978
396,340
214,558
1,826,840
162,800
2,223,180
377,358
(86,163)
(87,704)
2,137,017
289,654		 Trust
(Restated
– Note 6)
2021
2020
£
£
74,948
121,843
140
135
75,088
121,978
396,340
214,558
1,826,840
162,800
2,223,180
377,358
(86,163)
(87,704)
2,137,017
289,654
121,978
214,558
162,800
377,358
(87,704)
289,654
2,214,671
(3,620)
2,211,051
429,547
609,437
1,172,067
2,211,051		 423,302

(57,296)
366,006
130,901
-

235,105
366,006		 2,212,105
(3,620)
2,208,485
429,547
609,437
1,169,501
2,208,485		 411,632
(56,228)
355,404
130,901
-
224,503
355,404

The Trustees have prepared group accounts in accordance with section 398 of the Companies Act 2006 and section 138 of the Charities Act 2011. These accounts constitute the annual accounts required by the Companies Act 2006 and are for circulation to members of the company.

The financial statements were approved by the Trustees on 17 June 2022 and signed on their behalf by:

Diane Cutler

18

Wessex Cancer Trust (Registered Company No: 05416311

Consolidated Statement of Cash Flows for the year ended 31 December 2021

________________

Note
Cash generated from operating
activities
25
Cash flow from investing activities
Investment income
5
Sale of fixed assets
Purchase of tangible fixed assets
14
Cash used by investing activities
Cash flow from financing
activities
Drawdown of loan
Repayment of Loan
Cash used by financing activities
Increase in cash and cash
equivalents in the year
Cash and cash equivalents at the
beginning of the year
Total cash and cash equivalents at
the end of the year
Represented by:
Cash at bank		 Group
2021
2020
£
£
1,764,534
81,596
49
121
-
16,954
(12,699)
(20,261)
(12,650)
(3,186)
-
50,000
(50,000)

-
(50,000)
50,000
1,701,884
128,410
285,798
157,388
1,987,682
285,798
1,987,682
285,798		 Group
2021
2020
£
£
1,764,534
81,596
49
121
-
16,954
(12,699)
(20,261)
(12,650)
(3,186)
-
50,000
(50,000)

-
(50,000)
50,000
1,701,884
128,410
285,798
157,388
1,987,682
285,798
1,987,682
285,798
121
16,954
(20,261)
(3,186)
50,000
-
50,000
128,410
157,388
285,798
285,798

19

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

1 Principal accounting policies Basis of preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) - (Charities SORP (FRS102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006. The Charity is a public benefit entity as defined by FRS102.

The financial statements are prepared under the historical cost convention in sterling, which is the functional currency of the charity, as modified by the inclusion of investments at market value. Monetary amounts in these financial statements are rounded to the nearest £.

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus the accounts are prepared on a going concern basis.

Group financial statements

The statement of financial activities and balance sheet consolidate the financial statements of the Trust, and its subsidiary undertaking. The results of the subsidiary are consolidated on a line-by-line basis. A separate statement of financial activities and income and expenditure account are not presented for the charity itself following the exemptions afforded by section 408 of the Companies Act 2006. The parent company's result for the financial year was a profit of £1,853,081 (year to 31 December 2020: £102,784 loss.)

Fund accounting

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of the general objectives of the Trust and which have not been designated for other purposes.

Designated funds have been set aside by the Trustees for particular operational purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Trust for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Incoming resources

Donations and activities for generating funds are recognised in the period in which the Trust receives the income or when there is a reasonable assurance of receipt.

Income is deferred only when the Trust has to fulfil conditions before becoming entitled to it or where the donor has specified that the income is to be expended in a future period.

Legacies are included in the statement of financial activities on a receivable basis, being recognised at the point of notification of grant of probate when the Trust’s interest can be measured or estimated with sufficient reliability.

20

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as liability.

Investments and investment income

Investments held as fixed assets are stated at market value. Gains and losses on investments both realised and unrealised are included in the statement of financial activities. All income arising on investments is accounted for on a receivable basis.

Resources expended

All resources expended, including irrecoverable VAT, are charged against income on an accruals basis. Expenditure is allocated directly where the costs are directly attributable, otherwise on a basis of staff usage and their allocation of time.

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less their estimated residual value on a straight line basis over their expected useful economic lives as follows:

Leasehold Property over length of leases Motor Vehicles between 10% and 20% per annum Fixtures and Fittings between 15% and 33% per annum

No asset under £500 is capitalised.

Pensions

The Trust operates a group defined contribution pension scheme. Pension costs are charged to the Statement of Financial Activities as incurred.

Operating leases

Rental costs under operating leases are charged to the Statement of Financial Activities as incurred over the period of the leases.

2 Legacies

There is inherent uncertainty in the probate valuation of estates as a result of the nature of underlying assets and liabilities, the time that elapses between probate and closure and other contingencies that attend the estate. Legacies are recognised at the point of notification of grant of probate when it can be measured or estimated with sufficient reliability.

21

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

Note 2 Legacies – continued

A total amount of legacy income of £1,739,287 (2020: £72,237) was recognised in the year, and a balance of £163,394 was included within debtors as at the year end, which included £56,000 brought forward from 2020.

3 Activities for raising funds

ctivities for raising funds
Fundraising events and appeals
Retail turnover (see note 6)
Fundraising events and appeals

Retail turnover (see note 6)

ther income
Government furlough scheme
Government Covid-related grants
Government kickstart scheme
Insurance claims
Government furlough scheme
Government Covid-related grants		 Unrestricted
Funds
£
364,227
365,119		 Restricted
Funds
£
6,742
-
6,742
Restricted
Funds
£
31,420
-
31,420
Restricted
Funds
£
-
-
-
-
-
Restricted
Funds
£
-
-
-		 22
Total
31-12-2021
£
370,969
365,119
736,088
Total
31-12-2020
£
271,780
292,988
564,768
Total
31-12-
2021
£
42,287
71,145
40,456
53,451
207,339
Total
31-12-
2020
£
96,388
129,811
226,199
729,346
Unrestricted
Funds
£
240,360
292,988
533,348
Unrestricted
Funds
£
42,287
71,145
40,456
53,451
207,339
Unrestricted
Funds
£
96,388
129,811
226,199
207,339
Unrestricted
Funds
£
96,388
129,811
226,199

4 Other income

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

5 Investment income

Investment income
Bank interest
Investment income
Bank interest		 Unrestricted
Funds
£
2
47		 Restricted
Funds
£
-
-		 Total
31-12-2021
£
2
47
49 - 49
Unrestricted
Funds
£
2
119
121		 Restricted
Funds
£
-
-
-		 Total
31-12-2020
£
2
119
121

6 Income from trading activities of subsidiary

The Trust has a wholly owned trading subsidiary, W.C.T. Wessex Limited, which is incorporated in the UK, and whose principal activity is to carry on all of the trading activities for Wessex Cancer Trust.

Its trading results for the year, as extracted from the audited financial statements, are summarised below:

Profit and Loss Account
Profit and Loss Account
Turnover
Cost of Sales
Gross Profit
Expenses
Other income
Profit before taxation
Tax on profits
Profit for the Financial Year
Retained earnings brought forward
Amount gift aided to the Trust
Retained profit		 Total
31-12-2021
£
365,119
(5,407)
359,712
(301,366)
121,051
179,397
(659)
178,738
11,664
(190,402)
-		 Total
31-12-2020
£
292,988
(4,777)
288,211
(429,084)
178,525
37,652
1,067
38,719
46,102
(73,157)
11,664

23

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

Note 6 Income from trading activities of subsidiary - continued

The prior year Trust balance sheet has had the Intercompany balance in Debtors and Creditors, and Retained earnings restated to correct the accounting for the distribution from the subsidiary that was incorrectly entered. This restatement has no impact on the consolidated balance sheet at 31 December 2020 or the consolidated statement of financial activities.

7 Total expenditure

2021
Cost of generating funds (Note 9)
Provision of services (Note 11)
Support costs (Note 10)
Governance (Note 10)
2020
Cost of generating funds (Note 9)
Provision of services (Note 11)
Support costs (Note 10)
Governance (Note 10)		 Staff
costs
£
295,150
304,157
151,055
21,579
771,941
Staff
costs
£
351,676
257,755
200,385
28,626
838,442		 Depreciation
£
15,134
-
57,034
-
72,168
Depreciation
£
27,952
-
55,642
-
83,594		 Other
Costs
£
202,799
144,249
81,108
6,330
434,486
Other
Costs
£
253,970
156,660
65,947
7,096
483,673		 Total
31-12-21
£
513,083
448,406
289,197
27,909
1,278,595
Total
31-12-20
£
633,598
414,415
321,974
35,722
1,405,709

8 Net Incoming Resources for the year

Group Trust
2021 2020 2021 2020
This has been stated after charging: £ £ £ £
Operating lease rentals (Buildings) 143,844 229,161 89,561 87,410
Depreciation 72,168 83,594 59,594 55,642
Auditors remuneration
Audit Fee 10,025 9,325 8,875 8,225
Other Services 850 2,300
 - 1,500

24

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

9 Cost of generating funds

2021
Voluntary Income
Fundraising salaries
General fundraising costs
Trust organised event costs
Advertising and publicity
Activities for raising
funds
Shop and merchandising
costs:
Salaries
Other
Total

2020
Voluntary Income
Fundraising salaries
General fundraising costs
Trust organised event costs
Advertising and publicity
Activities for raising funds
Shop and merchandising costs:
Salaries
Other
Total		 Unrestricted
Funds
£
120,199
11,690
66,671
6,582
205,142
174,192
132,579
306,771
511,913
Unrestricted
Funds
£
151,123
13,671
19,611
12,742
197,147
200,398
233,460
433,858
631,005		 Restricted
Funds
£
759
-
-
411
1,170
-
1,170
Restricted
Funds
£
155
-
-
2,438
2,593
-
-
-
2,593		 Total
31-12-2021
£
120,958
11,690
66,671
6,993
206,312
174,192
132,579
306,771
513,083
Total
31-12-2020
£
151,278
13,671
19,611
15,180
199,740
200,398
233,460
433,858
633,598

25

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

10 Allocation of support and governance costs

2021
Staff costs
Depreciation
Office cost
Computer costs
Legal fees
Other professional
fees		 Total
2021
£
172,634
57,034
81,257
8,354
(8,503)
6,330
87,438
317,106		 Charitable
Activities
£
151,055
57,034
81,257
8,354
(8,503)
-
81,108
289,197		 Governance
Basis of
Allocation
£
21,579
Time
-
Usage
-
Usage
-
Usage
-
Usage
6,330
6,330
27,909

Charitable activities support costs are further analysed in note 10 and allocated 90% (2020: 90%) care and 10% (2020: 10%) education.

2020
Staff costs
Depreciation
Office cost
Computer costs
Legal fees
Other professional
fees		 Total
2020
£
229,011
55,642
69,254
3,834
(7,141)
7,096
73,043
357,696		 Charitable
Activities
£
200,385
55,642
69,254
3,834
(7,141)
-
65,947
321,974		 Governance
Basis of
Allocation
£
28,626
Time
-
Usage
-
Usage
-
Usage
-
7,096
7,096
35,722

26

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

11 Analysis of expenditure on charitable activities

2021
Care
Education
Provision of Services
Counselling
Complementary therapy		 Provision
of services
£
448,406
-
448,406		 Support
Costs
£
260,277
28,920
289,197
Unrestricted
Funds
£
198,036
2,615
200,651
Governance
£
25,118
2,791
27,909
Restricted
Funds
£
244,526
3,229		 Total
31-12-21
£
733,801
31,711
765,512
Total
31-12-21
£
442,562
5,844
247,755 448,406

2020

Care
Education		 Provision
of services
£
410,143
4,272
414,415		 Support
Costs
£
289,797
32,197
321,974		 Governance
£
32,150
3,572
35,722		 Total
31-12-20
£
732,070
40,041
772,111

Provision of Services

Counselling
Complementary therapy
Health education		 Unrestricted
Funds
£
158,322
4,190
1,693
164,205		 Restricted
Funds
£
241,247
6,384
2,579
250,210		 Total
31-12-20
£
399,569
10,574
4,272
414,415

27

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

12 Staff costs

Salaries
National insurance
Pension costs		 Unrestricted
Funds
£
575,917
38,427
14,358
628,702		 Restricted
Funds
£
138,797
3,373
1,068
143,238		 Total
31-12-21
£
714,714
41,800
15,426
771,940

One employee received remuneration between £60,000 and £70,000 per annum during 2021. In the prior year, no employee received remuneration of £60,000 or more.

The key management personnel of the group comprises the Trustees, the Chief Executive, Head of Fundraising and Communications, Head of Services, Head of Finance & Resources, Head of Marketing and Head of Retail. The total employee benefits of the key management personnel of the charity during the year were £242,342 (2020: £259,760).

The average number of employees during the period was 44 (2020: 47).

Pension costs outstanding at the year-end were £3,063 (2020: £2,833).

Redundancy payments totalling £262 were made during the year (2020: £3,034).

The Trust also acknowledges the help of part time volunteers on a regular basis and various other volunteers on an ad hoc basis, without which the Trust could not operate effectively.

Salaries
National insurance
Pension costs		 Unrestricted
Funds
£
628,153
53,012
13,850
695,015		 Restricted
Funds
£
139,969
2,786
672
143,427		 Total
31-12-20
£
768,122
55,798
14,522
838,442

13 Trustees’ remuneration and expenses

No Trustee received any remuneration during the year (2020: £nil).

28

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

14 Tangible fixed assets

Leasehold
Group
property
£
Cost
At 1 January 2021
418,859
Additions
-
Disposals
-
At 31 December 2021
418,859
Depreciation
At 1 January 2021
302,473
Charge for the period
57,019
Disposals
-
At 31 December 2021
359,492
Net book value
At 31 December 2021
59,367
At 31 December 2020
116,386
Trust tangible fixed assets
Leasehold
property
£
Cost
At 1 January 2021
188,352
Additions
-
Disposals
-
At 31 December 2021
188,352
Depreciation
At 1 January 2021
99,348
Charge for the period
44,445
Disposals
-
At 31 December 2021
143,793
Net book value
At 31 December 2021
44,559
At 31 December 2020
89,004		 Motor
vehicles
£
25,650
-
-
25,650
11,782
6,147
-
17,929
7,721
13,868
Motor
vehicles
£
25,649
-
-
25,649
11,783
6,147
-
17,930
7,719
13,866		 Fixtures &
fittings
£
165,370
12,699
(20,138)
157,931
146,396
9,002
(20,138)
135,260
22,671
18,974
Fixtures &
fittings
£
119,844
12,699
-
132,543
100,871
9,002
-
109,873
22,670
18,973		 Total
£
609,879
12,699
(20,138)
602,440
460,651
72,168
(20,138)
512,681
89,759
149,228
Total
£
333,845
12,699
-
346,544
212,002
59,594
-
271,596
74,948
121,843

29

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

15 Fixed asset investments

Fixed asset investments
represent:
Shares in subsidiary company
UK Listed Lloyds Banking
Group (100% of total)
Cash		 Group
2021
2020
£
£
-
-
24
19
114
114
138
133		 Trust
2021
2020
£
£
2
2
24
19
114
114
140
135		 Trust
2021
2020
£
£
2
2
24
19
114
114
140
135
135

Subsidiary company:

The Trust owns 2 ordinary shares of £1 representing 100% of the issued share capital of W.C.T. Wessex Limited.

Quoted investments:
Market value at 1 January
Realised gains
Unrealised gains
Market value at 31 December
Historical cost		 Group
2021
2020
£
£
19
34
-
(1)
5
(14)

24
19
119
119		 Trust
2021
2020
£
£
19
34
-
(1)
5
(14)
24
19
119
119		 Trust
2021
2020
£
£
19
34
-
(1)
5
(14)
24
19
119
119
19
119

16 Debtors

Group
2021
2020
£
£
Amounts falling due within
one year:
Trade debtors
27,854
3,579
Prepayments and accrued
income
220,295
158,640
Amounts due from subsidiary
-
-
Other debtors
-
12,353
248,149
174,572		 Trust
2021
(Restated
see Note 6)
2020
£
£
27,854
3,579
192,450
141,559
176,036
69,420
-
396,340
214,558		 Trust
2021
(Restated
see Note 6)
2020
£
£
27,854
3,579
192,450
141,559
176,036
69,420
-
396,340
214,558
214,558

30

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

17 Creditors: amounts falling due within one year

Trade creditors
Accruals and deferred income
Other creditors
Bounce Back Loan		 Group
2021
2020
£
£
48,783
118,401

35,414
40,019
26,860
24,460
-
3,549
111,057
186,429		 Trust
2021
(Restated
see Note 6)
2020
£
£
31,406
34,587
30,865
27,726
23,892
21,842
-
3,549
86,163
87,704		 Trust
2021
(Restated
see Note 6)
2020
£
£
31,406
34,587
30,865
27,726
23,892
21,842
-
3,549
86,163
87,704
87,704

18 Creditors: amounts falling due after more than one year

Other creditors
Bounce Back Loan		 Group
2021
2020
£
£
3,620
10,845
-
46,451
3,620
57,296		 Trust
2021
2020
£
£
3,620
9,777
-
46,451
3,620
56,228		 Trust
2021
2020
£
£
3,620
9,777
-
46,451
3,620
56,228
56,228

19 Financial commitments

At 31 December the group had the following commitments under non-cancellable property leases:

Payable:
Under 1 year
Between 2 and 5 years
Over 5 years		 Group
2021
2020
£
£
200,582
189,668
443,716
435,145
316
16,487
644,614
641,300		 Trust
2021
2020
£
£
96,000
83,793
185,500
258,312
-
16,487
281,500
358,592		 Trust
2021
2020
£
£
96,000
83,793
185,500
258,312
-
16,487
281,500
358,592
358,592

20 Restricted funds

estricted funds
(a) Patient transport
(b) Support Centres
Total
restricted
funds		 Balance
1-1-21
£

20,903
109,998
130,901		 Movement in resources
Incoming
Outgoing
£
£
20,858
(18,004)
528,524
(230,921)
549,382
(248,925)		 Transfers
£
-
(1,811)
(1,811)		 Balance
31-12-21
£
23,757
405,790
429,547

31

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

Note 20 Restricted funds - continued

Transfers relate to capital expenditure on the new Bournemouth Centre.

a) Children's
Fund
b) Patient
Transport
c) Support
Centres
Total restricted
funds		 Balance
1-1-2020
£
10,708
38,575
90,832
140,115		 Movement in resources
Incoming
Outgoing
£
£
-
(10,708)
4,925
(22,597)
240,660
(219,498)
245,585
(252,803)		 Transfers
£
-
-
(1,996)
(1,996)		 Balance
31-12-20
£
-
20,903
109,998
130,901

Transfers relate to capital expenditure on the Isle of Wight Centre rebuild.

21 Statement of funds

Total restricted funds
Unrestricted Funds
Designated funds
Unrestricted funds
Total Unrestricted
funds		 Balance
1-1-21
£
130,901
-
235,105
235,105
366,006		 Movement in resources
Incoming
Outgoing
£
£
549,382
(248,925)
-
-
2,573,854
(1,029,266)
2,573,854
(1,029,266)
3,123,236
(1,278,191)		 Transfers
£
(1,811)
609,437
(607,626)
1,811
-		 Balance
31-12-21
£
429,547
609,437
1,172,067
1,781,504
2,211,051

32

Wessex Cancer Trust (Registered Company No: 05416311

Notes forming part of the financial statements for the year ended 31 December 2021

________________

Note 21 Statement of funds - continued

Total restricted funds
Unrestricted funds		 Balance
1-1-20
£
140,115
328,675
468,790		 Movement in resources
Incoming
Outgoing
£
£
245,585
(252,803)
1,057,355
(1,152,921)
1,302,940
(1,405,724)		 Transfers
£
(1,996)
1,996
-		 Balance
31-12-20
£
130,901
235,105
366,006

The incoming and outgoing resources figures for the restricted fund include the gains and losses on investments in the year as per note 15.

Designated funds have been set aside by the charity out of the unrestricted legacies received during the year, to enable the charity to develop, improve and expand its reach and range of services as part of the Strategic Plan.

22 Analysis of net assets of the group’s funds

Restricted funds
Unrestricted funds
Designated funds
Unrestricted funds
Restricted funds
Unrestricted funds		 Tangible
fixed
assets
£
74,948
-
14,811
89,759
Tangible
fixed
assets
£
121,843
27,385
149,228		 Investments
£
138
-
-
138
Investments
£
133
-
133		 Net
assets/
(liabilities)
£
354,461

609,437

1,157,256

2,121,154

Net
assets/
(liabilities)
£
8,925
207,720
216,645		 Total
31-12-21
£
429,547
609,437
1,172,067
2,211,051
Total
31-12-20
£
130,901
235,105
366,006

23 Related party transactions

There were no related party transactions in the year (2020: £2,500 – in relation to sale of a company car to a Trustee).

33

Wessex Cancer Trust (Registered Company No: 05416311 Notes forming part of the financial statements for the year ended 31 December 2021

________________

24 Taxation

As a charity, the Trust is exempt from Corporation Tax on profits applied to charitable purposes, under Section 505 of the Income and Corporation Taxes Act 1988. The trading company uses the gift aid scheme to transfer an element of its profits to the Trust. In 2021 the trading company distributed its taxable profits to the Trust of £190,402 (2020: £73,157) under the gift aid scheme. A tax liability of £659 (2020: £nil) in the Subsidiary, was offset on reversing the deferred tax liability of £1,058 (2020: £nil).

25 Reconciliation of net movement in funds to net cash flow from operating activities

Net movement in funds
Add back depreciation charge
Add back (gain)/loss on disposal of tangible fixed assets
Deduct investment income shown in investing activities
Add back unrealised (gain)/loss on investments
(Increase)/decrease in debtors
Decrease in creditors		 Group
2021
2020
£
£
1,845,045
(102,784)
72,168
83,594
-
(6,081)
(49)
(121)
(5)
15
(73,577)
232,339
(79,048)
(125,366)
1,764,534
81,596		 Group
2021
2020
£
£
1,845,045
(102,784)
72,168
83,594
-
(6,081)
(49)
(121)
(5)
15
(73,577)
232,339
(79,048)
(125,366)
1,764,534
81,596
81,596

34